米国のネブライザー市場の成長と動向分析レポート

U.S. Nebulizer Market Growth & Trends

The U.S. nebulizer market size is anticipated to reach USD 412.6 million by 2030, according to a new report by Grand View Research, Inc., expanding at a 5.4% CAGR during the forecast period.

米国のネブライザー市場規模は 2030 年までに 4 億 1,260 万米ドルに達すると予想されており、予測期間中に 5.4% の CAGR で拡大します。

Rising incidence of chronic respiratory diseases in U.S., increasing demand for home healthcare devices, and growing geriatric population are among the key factors driving market growth.

Rising incidence of chronic respiratory diseases is a crucial driver for market growth. According to statistics published by the Centers for Disease Control and Prevention (CDC), approximately 18.4 million adults in U.S. suffer from asthma. Chronic obstructive pulmonary disease (COPD) was estimated to be the third leading cause of death in the country in 2014, according to the CDC, with around 15.7 million Americans diagnosed with the condition that year. Factors such as overconsumption of tobacco and alcohol, unhealthy diet, lack of physical activity, and alarming rates of obesity are also likely to lead to an increase in incidence of respiratory disorders in U.S., contributing to the growth of the nebulizer market over the forecast period.

Home healthcare devices have been gaining popularity and market share in recent years. Growing geriatric population in U.S., high incidence of target diseases, and rising need to curb healthcare expenditure are expected to be some of the high-impact rendering drivers for home healthcare devices. Home healthcare is a cost-effective alternative to expensive hospital stays. Easy availability of compact nebulizers ideal for home use and technological innovations in nebulizers to reduce noise and improve functionality are increasing their adoption in home healthcare. Moreover, third-party payers, such as insurance companies, favor such devices as they aim to reduce costs while providing quality healthcare services. Such factors are also expected to contribute to market growth.

U.S. Nebulizer Market Report Scope

U.S. Nebulizer Market Report Highlights

• Mesh is expected to register the fastest CAGR of 5.8% over the forecast period owing to its advanced technology that provides fast and highly effective drug delivery when compared to that of a usual nebulizer.

• The asthma segment dominated the market in 2023 and accounted for a market share of 40.0% driven by the high prevalence of asthma, which requires regular and effective administration of drugs for disease management.

• The hospitals and clinics segment dominated the market in 2023. The hospitals and clinics provide a controlled environment with physicians trained to administer nebulized drugs, especially for critical cases or patients who require intensive care.

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope

                    1.1. Market Segmentation and Scope

                    1.2. Market Definitions

                    1.3. Research Methodology

                        1.3.1. Information Procurement

                        1.3.2. Information or Data Analysis

                        1.3.3. Market Formulation & Data Visualization

                        1.3.4. Data Validation & Publishing

                    1.4. Research Scope and Assumptions

                        1.4.1. List of Data Sources

Chapter 2. Executive Summary

                    2.1. Market Outlook

                    2.2. Segment Outlook

                    2.3. Competitive Insights

Chapter 3. U.S. Nebulizer Market Variables, Trends, & Scope

                    3.1. Market Introduction/Lineage Outlook

                    3.2. Market Size and Growth Prospects (USD Million)

                    3.3. Market Dynamics

                        3.3.1. Market Drivers Analysis

                        3.3.2. Market Restraints Analysis

                    3.4. U.S. Nebulizer Market Analysis Tools

                        3.4.1. Porter’s Analysis

                            3.4.1.1. Bargaining power of the suppliers

                            3.4.1.2. Bargaining power of the buyers

                            3.4.1.3. Threats of substitution

                            3.4.1.4. Threats from new entrants

                            3.4.1.5. Competitive rivalry

                        3.4.2. PESTEL Analysis

                            3.4.2.1. Political landscape

                            3.4.2.2. Economic and Social landscape

                            3.4.2.3. Technological landscape

                            3.4.2.4. Environmental landscape

                            3.4.2.5. Legal landscape

Chapter 4. U.S. Nebulizer Market: Type Estimates & Trend Analysis

                    4.1. Segment Dashboard

                    4.2. U.S. Nebulizer Market: Type Movement Analysis, 2023 & 2030 (USD Million)

                    4.3. Jet

                        4.3.1. Jet Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

                    4.4. Mesh

                        4.4.1. Mesh Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

                    4.5. Ultrasonic

                        4.5.1. Ultrasonic Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 5. U.S. Nebulizer Market: Application Estimates & Trend Analysis

                    5.1. Segment Dashboard

                    5.2. U.S. Nebulizer Market: Application Movement Analysis, 2023 & 2030 (USD Million)

                    5.3. COPD

                        5.3.1. COPD Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

                    5.4. Asthma

                        5.4.1. Asthma Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

                    5.5. Others

                        5.5.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 6. U.S. Nebulizer Market: End Use Estimates & Trend Analysis

                    6.1. Segment Dashboard

                    6.2. U.S. Nebulizer Market: End Use Movement Analysis, 2023 & 2030 (USD Million)

                    6.3. Hospitals and Clinics

                        6.3.1. Hospitals and Clinics Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

                    6.4. Emergency Centers

                        6.4.1. Emergency Centers Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

                    6.5. Others

                        6.5.1. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)

Chapter 7. Competitive Landscape

                    7.1. Recent Developments & Impact Analysis by Key Market Participants

                    7.2. Company Categorization

                    7.3. Company Heat Map Analysis

                    7.4. Company Profiles

                        7.4.1. OMRON Healthcare, Inc.

                            7.4.1.1. Participant’s Overview

                            7.4.1.2. Financial Performance

                            7.4.1.3. Product Benchmarking

                            7.4.1.4. Recent Developments/ Strategic Initiatives

                        7.4.2. GE Healthcare

                            7.4.2.1. Participant’s Overview

                            7.4.2.2. Financial Performance

                            7.4.2.3. Product Benchmarking

                            7.4.2.4. Recent Developments/ Strategic Initiatives

                        7.4.3. Koninklijke Philips N.V.

                            7.4.3.1. Participant’s Overview

                            7.4.3.2. Financial Performance

                            7.4.3.3. Product Benchmarking

                            7.4.3.4. Recent Developments/ Strategic Initiatives

                        7.4.4. Allied Healthcare

                            7.4.4.1. Participant’s Overview

                            7.4.4.2. Financial Performance

                            7.4.4.3. Product Benchmarking

                            7.4.4.4. Recent Developments/ Strategic Initiatives

                        7.4.5. Vectura Group Plc.

                            7.4.5.1. Participant’s Overview

                            7.4.5.2. Financial Performance

                            7.4.5.3. Product Benchmarking

                            7.4.5.4. Recent Developments/ Strategic Initiatives

                        7.4.6. PARI Respiratory Equipment, Inc.

                            7.4.6.1. Participant’s Overview

                            7.4.6.2. Financial Performance

                            7.4.6.3. Product Benchmarking

                            7.4.6.4. Recent Developments/ Strategic Initiatives

                        7.4.7. Aerogen

                            7.4.7.1. Participant’s Overview

                            7.4.7.2. Financial Performance

                            7.4.7.3. Product Benchmarking

                            7.4.7.4. Recent Developments/ Strategic Initiatives

                        7.4.8. DeVilbiss Healthcare LLC

                            7.4.8.1. Participant’s Overview

                            7.4.8.2. Financial Performance

                            7.4.8.3. Product Benchmarking

                            7.4.8.4. Recent Developments/ Strategic Initiatives

                        7.4.9. Briggs Healthcare

                            7.4.9.1. Participant’s Overview

                            7.4.9.2. Financial Performance

                            7.4.9.3. Product Benchmarking

                            7.4.9.4. Recent Developments/ Strategic Initiatives

                        7.4.10. Beurer GmBH

                            7.4.10.1. Participant’s Overview

                            7.4.10.2. Financial Performance

                            7.4.10.3. Product Benchmarking

                            7.4.10.4. Recent Developments/ Strategic Initiatives

Grand View Researchについて

Grand View Research（グランドビューリサーチ） はインドと米国を拠点とする市場調査およびコンサルティング会社です。世界中主要 25ヵ国・ 46 業界に関する豊富なデータベースを活用した市場情報は世界の企業団体に活用・引用されています。日本からのレポートのご注文・ご購入相談はお気軽にお問い合わせください。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ 1

ライセンスタイプ 2

ライセンスタイプ 3

ライセンスタイプ 4

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス（インディビジュアルライセンス）
    • 1名のみレポートファイル（印刷不可）をご利用いただけます。
  • チームライセンス
    • 同一企業（関連会社除く）内5名まで共有可能です。印刷可能な電子ファイルをご提供いたします。
  • コーポレートライセンス
    • 同一企業および関連会社内で人数無制限で共有可能です。印刷可能な電子ファイルをご提供いたします。
    • 「関連会社」の範囲についてはお気軽にお問い合わせください。
• 納品形態
  • オンラインダウンロード
• 納期
  • ご注文後1～7営業日　※レポートにより異なります。

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

最新出版レポート

• ARクラウド市場規模、成長と動向分析レポート 2025-2033年
• ノーコードAIプラットフォーム市場規模、成長と動向分析レポート 2025-2033年
• 量子コンピューティングにおけるAI最適化市場規模、成長と動向分析レポート 2025-2033年
• ワイヤレス状態監視システム市場規模、成長と動向分析レポート 2025-2033年
• ゲームストリーミング市場規模、成長と動向分析レポート 2025-2033年

出版レポート一覧